U.S. FDA approves DECNUPAZ for adult patients with BPDCN, a rare aggressive Blood cancer

Datroway approved in the U.S. as first TROP2-directed ADC for 1L metastatic TNBC patients ineligible...

CHMP recommends EU approval of Enhertu for previously treated HER2-positive metastatic Solid tumours

Gilead receives CHMP positive opinion for Trodelvy in 1L metastatic TNBC patients ineligible for PD-(L)1...

Sino Biopharmaceuticals CLDN18.2 ADC LM-302 granted Priority Review with China approval expected

Adcendo and MSD partner to evaluate ADCE-T02 plus KEYTRUDA in phase 1b advanced Solid tumor...